---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-26-073439"
form_type: "8-K"
ticker: "LNTH"
cik: "0001521036"
company_name: "Lantheus Holdings, Inc."
filed_at: "2026-02-26T23:59:59+00:00"
generated_at: "2026-05-15T23:33:39.486565+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Lantheus Q4 revenue $406.8M, adj EPS $1.67; narrows focus to PET radiodiagnostics

## Summary
- Worldwide revenue $406.8M (+4% YoY); FY2025 revenue $1.54B; GAAP diluted EPS $0.82 Q4, $3.41 FY.
- Adjusted diluted EPS $1.67 Q4 (+4.7% YoY), $6.08 FY; PYLARIFY sales $240.2M (-9.7%).
- Company sharpens focus on innovative PET radiodiagnostics; pursuing alternatives for radiotherapeutic assets; completed SPECT divestiture to SHINE.
- FY2026 guidance: revenue $1.4B-$1.45B, adjusted diluted EPS $5.00-$5.25.
- Repurchased $100M of stock in Q4; cash and equivalents $359.1M after acquisitions.

## SEC filing metadata
- accession: 0001193125-26-073439
- form_type: 8-K
- ticker: LNTH
- cik: 0001521036
- company_name: Lantheus Holdings, Inc.
- filed_at: 2026-02-26T23:59:59+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1521036/000119312526073439/0001193125-26-073439-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1521036/000119312526073439/lnth-20260226.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-26-073439
- JSON: https://secwatch.observer/filing/0001193125-26-073439.json
- Plain text: https://secwatch.observer/filing/0001193125-26-073439.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.